Extracorporeal Photochemotherapy in the Treatment of Severe Graft-Versus-Host Disease
Authors:
- Hildegard T. GreinixHGHildegard T. Greinix
- Beatrix Volc-PlatzerBVBeatrix Volc-Platzer
- Robert M. KnoblerRKRobert M. Knobler
- 1 January 2000
- journal article
- review article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 36 (5-6) , 425-434
Abstract
Advances in posttransplant immunosuppression have to the present not been able to prevent the development of graft-versus-host disease (GVHD) in patients given related or unrelated stem cell grafts for cure of hematologic diseases. Patients with GVHD not responding to first line therapy with corticosteroids remain at high risk of death due to severe infections or organ failure. Extracorporeal exposure of peripheral blood mononuclear cells to the photosensitizing agent 8-methoxypsoralen and ultraviolet A radiation has been shown to be effective in treatment of selected T-cell mediated diseases, including cutaneous T-cell lymphoma and rejection after organ transplantation. Extracorporeal photochemotherapy (ECP) is also a safe and efficacious adjunct therapy for both acute and chronic extensive GVHD with skin and visceral involvement and resistance to conventional immunosuppressive therapy. A multicenter randomized study should help define the impact of ECP in the treatment of GVHD and overall survival of these patients.Keywords
This publication has 38 references indexed in Scilit:
- Bone Marrow Transplants from Unrelated Donors for Patients with Chronic Myeloid LeukemiaNew England Journal of Medicine, 1998
- Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donorsBone Marrow Transplantation, 1998
- Unrelated Donor Bone Marrow Transplantation for Chronic Myelogenous Leukemia: A Decision AnalysisAnnals of Internal Medicine, 1997
- IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADEBritish Journal of Haematology, 1997
- Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamideBlood, 1994
- Cytokine dysregulation and acute graft-versus-host diseaseBlood, 1992
- Graft-versus-Host DiseaseNew England Journal of Medicine, 1991
- T CELL DEPLETION FOR GRAFT-VERSUS-HOST-DISEASE PROPHYLAXISTransplantation, 1989
- Bone-Marrow TransplantationNew England Journal of Medicine, 1975
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974